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Scope: Selenium (Se) is incorporated into selenoproteins as selenocysteine, which requires
structures in the 3′-untranslated region (3′-UTR) of selenoprotein mRNAs. The functional con-
sequences of a single nucleotide polymorphism (SNP) within the 3′-UTR of the selenoprotein
GPX4 gene (GPX4c718t) was assessed in human umbilical vein endothelial cells (HUVECs)
and monocytes from human volunteers.
Methods and results: HUVEC and monocytes homozygous for the T- or C-variant of the
GPX4c718t SNP were assessed for monocyte–endothelial cell adhesion, expression of VCAM-1
and sensitivity to oxidative challenge. Interaction of the SNP with Se and different PUFA and
effects on selenoprotein expression were also investigated. HUVEC and monocytes homozy-
gous for the T-variant showed elevated adhesion levels compared to cells of the C-variant. This
effect was modified by Se and PUFA. HUVEC homozygous for the T-variant showed elevated
levels of VCAM-1 protein in the presence of arachidonic acid, were more sensitive to oxida-
tive challenge and showed Se-dependant changes in lipid peroxide levels and expression of
additional selenoproteins.
Conclusion: These findings demonstrate functional effects of the GPX4c718t SNP in endothe-
lial cells and may suggest that individuals with the TT genotype have impaired endothelial
function and are at greater risk of vascular disease compared to individuals with the CC
genotype.
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1 Introduction
Inappropriate diet may account for a significant propor-
tion of cardiovascular disease (CVD) [1], therefore under-
standing how specific nutrients or dietary regimes modu-
late cardiovascular function is an important area. Genetic
make-up also contributes to CVD risk and the interaction
of functional genetic variants with dietary components is
likely to underlie many multifactorial diseases including
CVD [2].
Suboptimal intake of the micronutrient selenium (Se) has
been associated with greater mortality as well as increased
risk of diseases including CVD, prostate, and colorectal can-
cers [3–5]. The metabolic functions of Se are thought to be
due to its presence as selenocysteine (Sec) in selenoproteins of
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which there are 25 in humans. Most selenoproteins, includ-
ing glutathione peroxidases (GPX) and thioredoxin reduc-
tases (TR), have antioxidant and redox functions that protect
cells from oxidative stress and cell damaging agents [6]. Con-
sequently, since low dietary intakes of Se may lower antioxi-
dant status this may increase the risk of diseases associated
with oxidative damage, namely, CVD and cancer.
Se is incorporated into selenoproteins as the amino acid
Sec during protein synthesis. Sec is encoded by aUGA codon,
which requires a specific RNA structure in the 3′-untranslated
region (3′-UTR) of selenoprotein mRNAs termed a Sec inser-
tion sequence. Under Se-limiting conditions, Se utilization
is specifically prioritized between and within tissues result-
ing in preferential expression of some selenoproteins to the
detriment of others [7]. This phenomenon is referred to as the
selenoprotein hierarchy and is in part due to differences in the
interaction of the different selenoprotein 3′-UTR sequences
with the Sec incorporationmachinery [6–8]. Accordingly, sin-
gle nucleotide polymorphisms (SNPs) within such a 3′-UTR
may have functional effects through not only affecting syn-
thesis of the selenoprotein encoded by that mRNA but also by
affecting the synthesis of additional selenoproteins because
of effects on the hierarchy [8, 9].
GPX4 (phospholipid hydroperoxide glutathione peroxi-
dase) is an intracellular antioxidant selenoprotein that can re-
duce lipid hydroperoxides within cell membranes, [reviewed
in [10]). GPX4 can also potentially modulate inflammation
through regulating leukotriene biosynthesis and cytokine-
signaling pathways [10,11]. A T/C variation (rs713041) in the
region of theGPX4 gene that corresponds to the 3′-UTR of the
mRNA is present inAsian andCaucasian populations [11,12].
Evidence suggests that this SNP is functional because studies
have shown it to be associated with differences in the levels
of 5-lipoxygenase metabolites in lymphocytes [11] and dif-
ferences in driving selenoprotein synthesis in reporter gene
studies [13, 14]. Moreover, results from a supplementation
study suggest that the SNP can affect expression of GPX4
and GPX1 in human lymphocytes, suggesting that the vari-
ants differ in their ability to interact with the Se incorporation
machinery [9]. Further studies have also provided evidence to
correlate this SNP with disease; the SNP is associated with
susceptibility to colorectal cancer and to increased risk of
death in breast cancer patients [13, 15]. More recently, the
SNP was also shown to be a predictor of stroke in patients
with hypertension [16].
The aim of the present work was to investigate the po-
tential role of the GPX4c718t SNP in cardiovascular function
by determining whether this SNP has functional effects in
human vascular endothelial cells (ECs) and to examine how
these aremodified by different dietary components including
Se and fatty acids; fatty acids are known to modulate mono-
cyte adhesion to endothelial cells [17, 18] and they can also
regulateGPX4 expression [19]. The recruitment ofmonocytes
from the circulation and their binding to and transmigration
across the lining of EC covering the artery into the intimal
space of the arterial wall is a key early event in atheroscle-
rosis development [20]. In order to determine the effect of
the GPX4c718t SNP on this process, Human umbilical vein
endothelial cells (HUVECs) genotyped for GPX4c718t and
homologous for either T (TT) or C (CC) were assayed for their
ability to bind monocyte cells under both basal and activated
conditions.
2 Materials and methods
2.1 Cell culture
Both pooled (fromfive different donors) and single-donor pri-
mary HUVEC (Greiner Bio-one) were routinely cultured as
per the manufacturer’s protocol in EGM-2 bulletkit medium
(which contains Se). For Se deficient experiments, HUVEC
cultured in EGM-2 medium were first washed three times in
1× PBS (Sigma-Aldrich) and then grown in M199 medium
(Gibco) (which contains no Se) with 10% fetal calf serum
(FCS) added (Sigma-Aldrich). FCS itself contained Se at
175 nM but this Se form was shown not to be bio-available
in that it did not support GPX activity. However, GPX1 activ-
ity was maximally stimulated after the addition of 40 nM
sodium selenite (data not shown). U937 cells (Sigma-
Aldrich) were maintained in RPMI-1640 medium (Sigma-
Aldrich) with 10%FCS, penicillin (1U/mL) and streptomycin
(1 g/mL; Gibco).
2.2 Recruitment and blood sampling of human
volunteers
Twenty healthy nonsmoking male volunteers aged between
25 and 55 years old were recruited from the general popula-
tion in the Aberdeen area. Exclusion criteria included those
taking aspirin or other anti-inflammatory drugs or medicines
known to alter the immune/haemostatic function; excessive
alcohol consumption (>30 units/wk); and those taking fatty
acid, multivitamin or other herbal supplements within the
previous 6 wk. Volunteers were asked to attend the Human
NutritionUnit at the Rowett Institute of Nutrition andHealth
on two separate occasions. At the first visit, a mouth swab
was taken for GPX4c718t genotyping of buccal cell DNA. At
the second visit, a fasted peripheral blood sample (40 mL)
was drawn from the antecubital vein into EDTA-tubes (BD
Vacutainer; Becton-Dickinson) and processed for monocyte
isolation and adhesion assays. Written informed consent was
obtained from all participants and the study was double-
blinded. The study protocol was approved by the North of
Scotland Research Ethics Committee (NOSRES; REC refer-
ence 08/0801/162).
2.3 Monocyte isolation from volunteers
Monocytes were isolated from fasted blood samples using
OptiPrepTM as per the manufacturer’s protocol (Axis-Shield).
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Flow cytometry using an anti-CD14-FITC antibody (BD Bio-
sciences) routinely demonstrated that>85% of the cells were
CD14+.
2.4 DNA extraction and genotyping
Buccal cell DNA was isolated from volunteer mouth swabs
usingQIAmp (Qiagen) according to themanufacturer’s spec-
ifications. Single donor HUVEC and U937 DNA were iso-
lated from around 5 × 105 cells using the QIAprep DNA kit
(Qiagen) and protocol. To determine the genotype for GPX4
718, a PCR was performed with 100 ng template genomic
DNA, using forward (5′-GACCTGCCCCACTATTTCTA-3′)
and reverse (5′-GTCTGTTTATTCCCACAAGG-3′) primers
and an Expand High-Fidelity PCR system (Roche) in a
Thermo-Hybaid Px2 thermocycler under the following con-
ditions: an initial denaturating step at 94C for 4 min,
followed by 30 cycles of denaturation (94C for 30 s),
annealing (53.5C for 30 s), and extension (72C for 1 min).
The PCR was completed by a final extension cycle at 72C
for 7 min. An aliquot of each PCR product was subjected to
electrophoresis in a 1× Tris-acetate-EDTA 1.5% agarose gel
and visualized with ethidium bromide as a 221-bp fragment.
PCR products were purified using a Qiagen PCR purification
kit as per the manufacturer’s protocol prior to DNA sequenc-
ing (Beckman Coulter CEQ 8000) to confirm the GPX4c718t
genotype. Of the 20 human volunteers recruited onto the
study, three were CC and five were TT for the GPX4c718t
SNP. Out of 18 aliquots of single donor HUVECs analyzed,
five were CC and five were TT for the GPX4c718t SNP.
2.5 Selenium deficiency and repletion of genotyped
HUVEC and selenoprotein assay
HUVECs genotyped for GPX4c718t (CC or TT) were grown to
subconfluence in EGM-2 medium containing bulletkit com-
ponents and then subcultured into Se-deficient conditions
(M199medium containing 10% FCS) (d0). Cells were kept in
this medium (fresh media replenished every 2 days) for up
to 9 days. After 5 days, 40 nM Se (as sodium selenite) was
added to some flasks for further 4 days (d9). Cells in both
flasks were harvested at day 0, 5, 7, and 9 and cell pellets were
assayed for total protein and selenoenzyme levels. HUVEC
extracts were assayed for GPX1 activity and GPX4 and TR1
protein by a competitive ELISA as described previously [14].
Total protein content wasmeasured by the bicinchoninic acid
assay method (Thermo Scientific).
2.6 Fatty acid treatments and monocyte-endothelial
adhesion assays
Pooled HUVECs were used to perform the monocyte–
endothelial adhesion assay when using genotypedmonocytes
from the human volunteers. For the assay using the geno-
typed HUVECs, U937 monocytes were used to test for ad-
hesion. HUVECs were grown in Se-deficient media with or
without Se (40 nM) for 5 days. After 3 days, cells were either
treated with 10 M arachidonic acid (ARA) (22:4n-6), linoleic
acid (LA) (18:2n-6), docosahexaenoic acid (DHA) (22:6n-3),
or ethanol alone for 2 days. Fatty acids (Cayman Chemicals;
99% pure free) were dissolved in 100% ethanol and stored
at −20C under nitrogen in the dark. Cells were then plated
overnight to confluence into 96-well plates and some wells
were challenged with TNF- (Source Biosciences, 5 ng/mL)
for 6 h and then all wells were washed twice in prewarmed
M199 medium and then 3 × 104 labeled monocytes/well
were added for 30 min. Monocytes were previously labeled
with 5 M BCECF-AM (Invitrogen) for 30 min, and then
washed three times with 1× PBS containing 1% FCS before
resuspending in M199 medium. After incubation of the HU-
VEC with the monocytes, wells were washed three times in
1× PBS containing 1% FCS to remove unbound monocytes,
then fluorescence was measured (excitation/emission was
488/530 nm). Control wells containing either no HUVECs
or no monocyte additions were used to calculate background
fluorescence.
2.7 Cell lipid peroxidation measurement
HUVECs genotyped for GPX4c718t were cultured in M199
medium plus 10% FCS in the presence or absence of
40 nM sodium selenite for 5 days. Cells were seeded onto
96-well plates at 3 × 104 cells/cm2 in the same medium and
left overnight. Cells were then incubated in the presence
of 5 M C11-BODIPY581/591 (4,4-difluoro-5-(4-phenyl-1,3-
butadienyl)-4-bora-3a,4adiaza-s-indacene-3-undecanoic acid)
(Invitrogen/Molecular Probes) for 30 mins at 37C. After
rinsing cells twice in enriched DPBS+ (137 mM NaCl,
2.7mMKCl, 0.5mMMgCl2, 0.9mMCaCl2, 1.5mMKH2PO4,
8.1 mM Na2HPO4, and 5 mM glucose, pH 7.4), oxidation of
C11-BODIPY581/591 was determined by measuring fluores-
cence at 590/520 nm (excitation/emission). Some cells were
also challenged with 0.1 mM tert-butylhydroperoxide (TBH)
(Sigma-Aldrich) in DPBS+ to induce oxidative stress. Wells
containing cells only were used to calculate background fluo-
rescence levels.
2.8 Cell viability assays
A total of 96-well plates were seeded with 6× 104 cells/cm2 of
genotyped HUVECs and grown in M199 medium plus 10%
FCS in the presence or absence of 40 nM sodium selenite.
After 5 days, cells were challenged with 0.3 mM TBH for 4 h
and then fresh medium was added to the cells. Cell viability
was assessed by the addition of 20 L of CellTiter-Blue R©
reagent (Promega) for 4 h and absorbance was measured at
560 nm. This assay is based on the ability of living cells to
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convert resazurin, a redox dye, into a fluorescent end product
(resorufin). Nonviable cells rapidly lose metabolic capacity
and do not generate a fluorescent signal.
2.9 Protein expression analysis
Protein extraction from HUVEC and Western blot analysis
was done as described previously [18] using 10% SDS-PAGE
and a rabbit anti-VCAM1 antibody (Insight Biotechnology)
andmouse anti--Actin antibody (Sigma-Aldrich) as a loading
control.
2.10 Statistical analysis
Experiments were carried out at least three times in duplicate
or triplicate and the results are presented as means ± SEM.
Comparison of several treatments was evaluated by analysis
of variance (ANOVA) on the log-transformed data, followed
by post-hoc t-tests.
3 Results
3.1 Effect of GPX4c718t genotype in HUVEC on
adhesion to monocytes: Effect of Se and PUFA
The U937 monocytic cell line was used in these experiments
and genotype analysis of these cells established it to have
the CC genotype at the GPX4c718t SNP. HUVEC genotyped
for GPX4c718t were assayed for their ability to bind U937
monocytes with and without a TNF- challenge. This lat-
ter challenge mimics the inflammatory conditions occurring
within the endothelium resulting in increased monocyte ad-
hesion that contributes to development of CVD.Wewere also
interested in determining whether PUFA-induced changes
in monocyte–endothelial adhesion were modified by the
GPX4c718t SNP. PUFA such as DHA, LA, and arachidonic
acid (ARA) are known to modulate monocyte–endothelial
adhesion [17, 18, 30, 31], a process which may be mediated
through the PUFA-induced formation of distinct eicosanoid
species [21]. Since GPX4 activity has also been shown tomod-
ulate cellular eicosanoid levels [11], this provided a rational
for investigating the interaction between the SNP and PUFA
on the adhesion process. Four-way ANOVA analysis demon-
strated that HUVEC with the TT genotype exhibited an over-
all 15% increase in adhesion (p< 0.001) compared to the CC
genotype (Fig. 1). Additionally, there was an effect of fatty
acid, Se, and TNF- on adhesion levels and an interaction of
fatty acid and TNF- (all p< 0.001) and genotype with TNF-
(p < 0.05) with all other interactions being nonsignificant.
In Se-deficient cells under basal conditions, monocyte ad-
hesion to HUVECs with the TT genotype was significantly
greater (32%; p < 0.05) compared with cells with the CC
genotype (Fig. 1A). Under Se-replete conditions, there was no
significant difference in monocyte adhesion between cells of
either genotype.However, in the presence of Se, cells with the
TT genotype exhibited a 26% decrease (p< 0.01) inmonocyte
adhesion compared to TT cells in the absence of Se (Fig. 1A).
This latter effect was also manifest in cells challenged with
TNF-; cells of the TT genotype exhibited lowermonocyte ad-
hesion (24%; p < 0.01) after Se supplementation compared
with the absence of Se (Fig. 1A). LA pretreatment of the
HUVEC had no additional effects on the level of adhesion
compared to treatment without fatty acid (Fig. 1B). ARA pre-
treatment invoked an average 37% increase in adhesion in
the absence of TNF- challenge irrespective of Se presence
(p < 0.05 or less), whereas it invoked decreased monocyte
adhesion (average 18%) in the presence of TNF- (p < 0.01
or less) except in Se-replete, TT cells (Fig. 1C). With DHA
pretreatment, there were no differences in adhesion levels in
the absence of TNF- challenge compared with no fatty acid
pretreatment, whereas upon TNF- challenge, HUVECs of
either genotype exhibited a reduction in adhesion (p < 0.05)
in the absence but not in the presence of Se (Fig. 1D).
3.2 Effect of GPX4c718t genotype in HUVEC on
VCAM-1 protein expression
To gain insight into the mechanism involved in the effect
of the GPX4c718t SNP in HUVEC on monocyte adhesion,
the protein levels of VCAM-1 were assayed in cells pretreated
with ARA as this treatment showed the greatest genotype
difference on adhesion levels (Fig. 1). Three-way ANOVA
analysis showed HUVEC with the TT genotype exhibited in-
creased VCAM-1 levels overall compared to those with the
CC genotype (p < 0.006). Additionally, there was an effect of
TNF- (p< 0.001) and an interaction of genotype and TNF-
(p < 0.009), with TT cells showing increased expression of
VCAM-1 in the presence of TNF- (Fig. 2).
3.3 Effect of monocyte GPX4c718t genotype on
adhesion to EC
The effect of the GPX4c718t SNP on monocyte function
was assessed by assaying the adhesion of monocytes iso-
lated from genotyped human volunteers to HUVECs (iso-
lated from five nongenotyped donors). Again, HUVECs were
either pretreated with LA or ARA or untreated to investigate
the response to fatty acids. Four-wayANOVAanalysis demon-
strated that TT monocytes exhibited an overall 39% increase
in adhesion compared to CC monocytes (p < 0.001). Addi-
tionally, there was an effect of fatty acid, Se, and TNF- on
adhesion levels and an interaction of fatty acid and TNF- (all
p < 0.001) with all other interactions being nonsignificant.
Without fatty acid pretreatment of the HUVEC, monocytes
with the CC genotype showed decreased adhesion to HU-
VEC in the presence of Se, irrespective of TNF- challenge
(p < 0.05; Fig. 3A). LA pretreatment of HUVEC was without
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Figure 1. Effect of the
GPX4c718t SNP in HUVEC
and fatty acid pretreatment on
monocyte adhesion. HUVECs
genotyped for GPX4c718t (CC
or TT) were grown to conflu-
ence under Se replete or Se
deficient conditions (+Se and
−Se) and challenged with TNF-
 and the number of adhering
monocytes was assayed. Cells
were either pretreated with
no fatty acid (A) or had prior
pretreatment with linoleic acid
(B), ARA (C), or docosahex-
anoic acid (D) at 10 M for
48 h. All values are expressed
as a percentage (± SEM)
of the value obtained for the
level of monocyte adhesion
to cells of the CC genotype
after TNF- challenge in the
absence of Se and fatty acid.
Statistical analysis was carried
out by four-way ANOVA on the
log-transformed data followed
by post hoc t-tests (*p < 0.05,
and **p < 0.01).
additional effect when compared to treatment without fatty
acid (Fig. 3A versus 3B). However, pretreatment of HUVEC
with ARA, while having no effect on adhesion levels in the
absence of TNF-, had a significant lowering effect on adhe-
sion levels in the presence of TNF- (all p < 0.05 or greater)
which was more prevalent in cells of the CC genotype com-
pared with those of the TT genotype (an average reduction of
60% versus 37% respectively; Fig. 3C).
3.4 Effect of GPX4c718t SNP on GPX4, GPX1, and
TR1 selenoenzyme levels
To establish whether the GPX4c718t SNP affected GPX4 lev-
els in ECs, HUVEC homozygous for CC or TT at position
718 were grown in the presence and absence of Se and GPX4
protein levels determined by ELISA. In addition, cells made
Se deficient for 5 days were then repleted with Se for fur-
ther 4 days in order to assess the response of GPX4 levels
to Se repletion. There were no differences in GPX4 protein
in cells with the CC genotype compared with cells with the
TT genotype in either Se adequate conditions or in those de-
ficient for Se after 5 days (Fig. 4A, d0, and d5). However,
in cells of both genotypes, GPX4 protein was downregulated
by 45% (p < 0.05) after Se deficiency for 5 days (Fig. 4A).
Further deficiency for 7 or 9 days did not result in any fur-
ther statistically significant changes in GPX4 levels in either
genotype (Fig. 4A). GPX4 levels increased significantly 2 days
(d7) (p < 0.01) and 4 days (d9) (p < 0.05) after Se repletion
in HUVEC with the CC genotype compared with levels at
d5 but no significant increase was found in the cells of TT
genotype (Fig. 4A). However, there were no significant dif-
ferences in GPX4 protein levels between genotypes after Se
repletion. Since there is a hierarchy in selenoprotein synthe-
sis, which results from competition for available Se and for
components of the selenoprotein synthetic machinery [7, 8],
the levels of GPX1 and TR1 were also measured alongside
those of GPX4. No significant differences in GPX1 activity
were observed between cells of either genotype in either Se
adequate or Se deficient cells after 5 days, similar to results
with GPX4 (Fig. 4B). After 5 days of Se deficiency, GPX1 ac-
tivity had decreased to around 47% (p < 0.05) of the activity
in replete cells. GPX1 activity was further reduced (to 25%
of the original level at d0) upon Se deficiency for additional
2 days (d7), which was significant for the CC genotype (p <
0.05) compared with d5 (Fig. 4B). In addition, when Se was
added back to cellsmade Se deficient for 5 days, GPX1 activity
was increased by 49% in cells with the TT genotype but not
in cells with the CC genotype after 2 days (p < 0.05; Fig. 4B).
After 4 days of Se repletion (d9), the GPX1 activity of the TT
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Figure 2. Effect of the GPX4c718t SNP in HUVEC on VCAM-1
protein levels after ARA pretreatment. HUVECs genotyped for
GPX4c718t (CC or TT) were grown to confluence under Se replete
or Se-deficient conditions (+Se and −Se) and were pretreated
with ARA at 10 M for 48 h. After challenge with TNF-, the levels
of VCAM-1 protein were assessed with representative Western
blots shown above. All values are expressed as a percentage
(± SEM) of the value obtained for VCAM-1 levels in HUVEC with
the CC genotype after TNF- challenge in the absence of Se. Sta-
tistical analysis was carried out by three-way ANOVA followed by
post hoc t-tests (*p < 0.05 and **p < 0.01).
genotype cells was 90% greater than the GPX1 activity in cells
of the CC genotype (p < 0.01; Fig. 4B).
TR1 protein levels were found to be higher (65%) in
cells with the CC genotype compared to cells with the TT
genotype under Se-adequate conditions (p < 0.05; Fig. 4C).
However, Se deficiency for 5, 7, or 9 days did not result in
any significant differences in TR1 levels between genotypes
(Fig. 4C). After Se repletion, TR1 levels in cells with the TT
genotype increased (by 63%; p < 0.05), whereas TR1 in cells
with the CC genotype showed no increase and remained low
(Fig. 4C).
3.5 Effect of GPX4c718t SNP in HUVEC on cellular
lipid peroxidation levels
Since HUVECs containing either TT or CC at position 718
of the GPX4 gene demonstrated differences in antioxidant
selenoprotein expression, levels of oxidative stress were mea-
sured in cells with respect to the GPX4c718t SNP using
C11-BODIPY581/591. This latter reagent is a lipophilic reporter
probe, which is incorporated into membranes where it is
mainly oxidized by chain-propagating species such as peroxyl
and alkoxyl radicals [22]. When cells were grown in the ab-
sence of Se, there were no differences in the level of lipid
A
B
C
Figure 3. Effect of the GPX4c718t SNP in monocytes and EC fatty
acid pretreatment on adhesion to HUVECs. Monocytes from vol-
unteers genotyped for GPX4c718t (CC or TT) were isolated and
added to HUVECs grown in the presence or absence of Se (+Se
and −Se) and challenged with TNF- and the number of adher-
ing monocytes was assayed. Cells were either pretreated with no
fatty acid (A) or pretreated with either linoleic acid (B) or ARA
(C) at 10 M for 48 h. Values are expressed as means ± SEM.
Statistical analysis was carried out by four-way ANOVA on the
log-transformed data followed by post hoc t-tests (*p < 0.05,
**p < 0.01 and ***p < 0.001).
peroxides in cells of either genotype. However, in the pres-
ence of Se, cells with the CC genotype had much lower (15%)
levels (p < 0.05) of lipid peroxides compared to cells with
the TT genotype (Fig. 5). Overall, lipid peroxide levels in CC
cells were lower in the presence of Se (p< 0.01) compared to
levels in the absence of Se, whereas in TT cells, the presence
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Figure 4. Effect of GPX4 718 SNP on GPX4, GPX1, and TR1 se-
lenoenzyme levels. Genotyped HUVECs (CC or TT at GPX4 718)
were initially cultured in Se replete medium (d0). Cells were then
washed and cultured in Se deficient medium for 5, 7, or 9 days
(d5, d7, d9). After five days of deficiency, some cells were supple-
mented with 40 nM Se for two days (d7+) or four days (d9+). At
each time point, the levels of GPX4 protein (A), GPX1 activity (B),
and TR1 protein (C) were measured. Values shown are means ±
SEM. Student’s t-test was used to test for significant differences
(*p< 0.05 and **p< 0.01 for comparison of CC and TT genotypes
and †p < 0.05 and ‡p < 0.01 when compared to value at d5).
Figure 5. Effect of GPX4 718 SNP on lipid peroxide levels.
HUVECs genotyped for GPX4c718t (CC or TT) were grown to
confluence under Se deficient or replete conditions (−Se and
+Se) and levels of lipid peroxides were measured using C11-
BODIPY581/591. Lipid peroxide levels are expressed as a percent-
age of those in cells of the CC genotype without Se. Values shown
are means ± SEM. Student’s t-test was used to test for significant
differences (*p < 0.05).
of Se had no significant effect (Fig. 5). When cells were chal-
lenged with TBH, levels of lipid peroxides were significantly
increased but there was no effect of the GPX4c718t SNP (not
shown).
3.6 Effect of GPX4c718t SNP in HUVEC on cell
viability
Since selenoprotein expression appeared different in
HUVECs of the CC and TT genotype depending on the
Se supply, experiments were carried out to assess if the
GPX4c718t genotype affected cell viability and if this was
modified by Se availability. HUVECs of either genotype
showed no change in cell viability in the presence or absence
of Se (Fig. 6), therefore viability after an oxidative challenge
was also measured. HUVEC viability was reduced in cells of
either genotype after challenge with the oxidant TBH in the
absence of Se (Fig. 6). In the presence of Se, the viability of
cells with the CC genotype was not significantly affected after
TBH challenge but the viability of cells with the TT genotype
was reduced by 75% (p < 0.01; Fig. 6).
4 Discussion
Earlier studies have provided evidence that the T/C variation
rs713041 within the GPX4 gene region corresponding to the
3′-UTR of the mRNA has functional consequences [9, 11,
13, 14]; the variants have distinct protein binding properties
and homozygous carriers show altered selenoprotein levels
and different levels of 5-lipoxygenase total products within
lymphocytes. The present results support and extend these
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Figure 6. Effect of the GPX4 718 SNP and Se availability on cell
viability. Genotyped HUVECs (CC or TT at GPX4 718) were grown
for 4 days in M199 medium with 10% FCS in the presence or ab-
sence of 40 nMSe. Cell viability wasmeasured after 4 h treatment
with 0.3 mM TBH and is shown as a percentage of untreated CC
cells grown in the absence of Se. Values shown are means ±
SEM. Student’s t-test was used to test for significant differences
(*p < 0.05, **p < 0.01, ***p < 0.001).
observations by showing that the SNP is functionally active in
relation to adhesion events in vascular cells, which may have
relevance to cardiovascular health and disease progression.
In the presence of Se, EC homozygous for the T-variant of
the GPX4c718t SNP were shown to be more sensitive to ox-
idative challenge and to have higher levels of lipid hydroper-
oxides compared with cells homozygous for the C-variant.
Conversely, there was no effect of the SNP on the sensitivity
to oxidative challenge or lipid peroxide levels in the absence
of added Se. Both EC and monocytes from volunteers ho-
mozygous for the T-variant of the GPX4c718t SNP were also
shown to exhibit increased levels of adhesion compared to
cells homozygous for the C-variant. Moreover, the effects of
the T-variant of the GPX4c718t SNP on monocyte-EC ad-
hesion in vivo will likely be additive to the separate effects
measured here using nonhomologous cell types with respect
to the GPX4c718t SNP. Monocytes are the primary inflam-
matory cells localized to human atherosclerotic plaques and
monocyte binding to EC is an important step in atheroscle-
rosis development [20,23]. Consequently, the finding that EC
and monocytes from individuals with the TT genotype show
both increased sensitivity to oxidative challenge and increased
adhesion suggests that these individuals may have a greater
susceptibility to endothelial damage and activation and there-
fore increased potential risk of associated disease.
TR1 has been suggested to be particularly important in
protectingEC from tert-butyl hydroperoxide induced oxidative
damage due to its relative abundance and ability to detoxify
some damaging lipid hydroperoxides more efficiently than
GPXs [24,25]. Interestingly, our findings support such a role
for this selenoprotein since EC homozygous for the C-variant
of the SNP expressed higher amounts of TR1 but not GPX1 or
GPX4 under Se-adequate conditions (Fig. 4C). Additionally,
increased levels of plasma TR1 protein have been observed
previously in female volunteers with the CC genotype after
supplementation with Se for 6-wks compared to females with
the TT genotype [9].
The GPX4c718t SNP was also found to differentially af-
fect GPX1 activity in EC under Se deficiency and repletion
and overall there was also a trend for cells with the TT geno-
type to respond better to Se repletion by increasing TR1 and
GPX4 protein levels. The finding that a SNP in GPX4 affects
the expression of other genes such as TR1 and GPX1 can be
explained by the hierarchical nature of selenoprotein expres-
sion in response to Se supply. Selenoproteins can compete
between themselves for available Se (selenocysteine) and for
components of the selenoprotein synthetic machinery [6–8].
This competition is driven, at least in part, by differences in
the sequence of the selenoprotein 3′-UTRs and therefore po-
tential polymorphismswithin these regions have the ability to
change the hierarchal order and alter expression of other se-
lenoproteins. Since earlier work has shown theC-variant to be
more effective than the T-variant in incorporating Se within a
reporter construct [13], we hypothesise that uponSe repletion,
GPX1 activity is higher in EC expressing the T-variant since
the C-variant is better able to compete against GPX1 for in-
corporation of Se into GPX4. In this regard, it is important to
note that human volunteers who are TT or CC for this variant
in GPX4 show different responses in the GPX1/GPX4 ratio
following changes in Se supplementation and RNA–protein
binding assays in vitro indicate that the C-variant competes
more strongly for binding proteins than the T-variant or the
GPX1 3′-UTR [9]. Preliminary screening of human gene ex-
pression microarrays comparing EC cells of the CC versus
the TT genotype also identified three other selenoproteins
that were differentially expressed with the GPX4c718t SNP
(GPX3, SELW1, and SELV) demonstrating further evidence
for effects of the SNP on the selenoprotein hierarchy (data
not shown).
Monocyte attachment to EC occurs through the expres-
sion of adhesion molecules (CAM) upon the EC surface in
response to multiple stimuli including TNF- [20]. Measure-
ment of the levels of VCAM-1 protein (at least after ARA pre-
treatment) showed a strong correlation between the reduction
in TNF--induced monocyte adhesion and lower expression
of VCAM-1 in HUVEC with the CC genotype compared to
cells with the TT genotype, indicating a likely mechanism for
the genotype effect. CAM expression involves the activation
of the NF-B transcription factor [26] and previous studies
have shown that Se can attenuate binding between these cell
types [27] and inhibit NF-B signaling [28,29]. Measurement
of NF-B activation in cells with respect to the SNP would
shed further light on the mechanism involved. Overexpres-
sion and knock-down studies have implicated GPXs in the
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inhibition of NF-B [28–30], but the precise role of Se and of
the individual selenoproteins in this process have not been
defined. As we have shown that the GPX4c718t SNP can al-
ter the selenoprotein hierarchy it is likely that the observed
effects on monocyte adhesion are mediated through changes
in selenoprotein expression and subsequent differential at-
tenuation of NF-B activation.
The GPX4c718t SNP was also shown to interact with fatty
acid treatment and to modulate the effect of certain PUFA
onmonocyte adhesion to EC. Upon a pro-inflammatory chal-
lenge, the PUFA-induced reduction in monocyte adhesion
to EC was impaired under Se-deficient conditions in EC ho-
mozygous for the T-variant (Fig. 1). This was also apparent
for binding of monocytes homozygous for the T-variant to EC
treated with ARA (Fig. 3). Dietary fatty acids have been shown
tomodulate monocyte adhesion to EC both in vitro [17,18,31]
and in vivo [32] and they have also been shown to modulate
Se status through regulation of selenoprotein expression [19].
These results indicate that the beneficial effects of certain di-
etary fatty acids in attenuating interaction of monocytes with
the EC may be reduced in individuals with the TT genotype,
particularly when dietary Se is limiting. This finding provides
further evidence of a likely adverse effect on vascular health
that individuals with the TT genotype exhibit compared with
individuals with the CC genotype.
In conclusion, the results presented here strengthen
the evidence for the GPX4c718t SNP being functional and
indicate that variants of this SNP can have detrimental conse-
quences on endothelial function. In particular, EC homozy-
gous for the T-variant of the SNP are more sensitive to
oxidative challenge and show elevated levels of monocyte ad-
hesion in response to dietary components compared to indi-
viduals homozygous for the C-variant of the SNP. Together
these findings suggest that individuals with the TT genotype
have inferior EC function and are therefore potentially more
prone to disease. Additional studies are needed to define how
the SNP affects the overall selenoprotein hierarchy and mod-
ifies individual selenoprotein function in the vasculature in
order to fully characterize its impact on cardiovascular health
and disease susceptibility.
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